Lung cancer screening: current situation and perspective, Swiss Med Wkly, vol.137, pp.304-311, 2007. ,
Bid-induced Conformational Change of Bax Is Responsible for Mitochondrial Cytochrome c Release during Apoptosis, The Journal of Cell Biology, vol.391, issue.5, pp.891-901, 1999. ,
DOI : 10.1074/jbc.272.39.24101
A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations, British Journal of Cancer, vol.311, issue.8, pp.998-1004, 2006. ,
DOI : 10.1093/annonc/mdi340
ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines, Proceedings of the National Academy of Sciences, vol.102, issue.10, pp.3788-3793, 2005. ,
DOI : 10.1073/pnas.0409773102
Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways, Science, vol.305, issue.5687, pp.1163-1167, 2004. ,
DOI : 10.1126/science.1101637
Gefitinib Induces Apoptosis in the EGFRL858R Non-Small-Cell Lung Cancer Cell Line H3255, Cancer Research, vol.64, issue.20, pp.7241-7244, 2004. ,
DOI : 10.1158/0008-5472.CAN-04-1905
Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo, Oncogene, vol.9, pp.1799-1805, 1994. ,
Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction inserm-00425468, version 1 -21 Oct 2009 invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma, Oncogene, vol.27, pp.4830-4840, 2006. ,
Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition, Gene Therapy, vol.73, issue.9, pp.635-651, 2008. ,
DOI : 10.1038/sj.bjc.6690811
A human tumor lung metastasis model in athymic nude rats, Cancer Res, vol.49, pp.5148-5152, 1989. ,